In this work we have validated a method to standardize and control the quality of Eucalyptus globulus raw material and phytomedicines containing either the essential oil or the fluid extract of this plant in the final formulation. Internal standardization provided a simple, fast, and reproducible GC-FID analytical method that accurately quantified 1,8-cineol in different E. globulus sub-products, such as its essential oil, dried leaves, fluid extract, and syrup. In addition, GC-MS identification of the main compounds of E. globulus species afforded fingerprints for the qualitative analysis of different Eucalyptus species.
Phytomedicines are medicinal products that contain complex mixtures of one or more plants in the crude or processed state, as well as excipients like solvents, diluents, and preservatives. Compared with conventional drugs, the active principles of phytomedicines are frequently unknown, which makes their standardization a challenge [1, 2] . The use of validated, simple, and environmentally friendly analytical methods to standardize these preparations provides essential data about the quality of these products, thereby ensuring the desired therapeutic effects [3] . Generally, the quality control of plant materials and phytomedicines relies on the identification and quantitation of chemical markers. This confirms the presence of specific compounds, but it might not attest to the identity of the desirable plant material. An alternative strategy to authenticate samples is to conduct chromatographic fingerprinting, which allows for comprehensive analysis of chemical profiles. For this purpose, several hyphenated chromatographic techniques, such as high performance liquid chromatography (HPLC-DAD/MS) and gas chromatography (GC-FID/MS) have found extensive application [4] .
Bearing in mind that information about the standardization of phytomedicines is lacking, and that establishing reliable methods to control their quality is essential, in this work we employed the versatile and widespread genus Eucalyptus to develop a practical model to produce and analyze phytomedicines. E. globulus (Myrtaceae) is one of the most widely used medicinal plants worldwide. Due to its expectorant, mucolytic, and antiseptic effects, it has traditionally been applied to treat respiratory diseases [5] . The biological properties of this plant have been attributed to the essential oil obtained from the fresh leaves of E. globulus, which is rich in monoterpenes such as 1,8-cineol, α-pinene, globulol, limonene, p-cimene, aromadendrene, mircene, γ-terpinene, and αterpineol [6, 7, 8] . Although the chemical profile of E. globulus is rich, quality control of this species relies on quantitation of its major constituent, the monoterpene 1,8-cineol, in the essential oil. 1,8-Cineol is highly volatile and may be lost during sample preparation. Therefore, we improved the method by using internal standardization, which made the analyses more reliable. To validate the method, we assessed the following parameters: specificity, linearity, detection and quantitation limits, accuracy, precision, and robustness [3] . Analysis of the chromatographic data (retention time and resolution) of E. globulus leaves, fluid extract, essential oil, and syrup against the control (syrup without plant extract) and against an n-hexanes solution containing 1,8-cineol only helped us to determine specificity. GC-MS revealed excellent separation with good resolution and peak purity for all the samples.
Injection of standard solutions with distinct concentrations and examination of the linear regression of the responses aided determination of the linearity. The linear correlation coefficients were 0.9993 for 1,8-cineol (y = 1.1521x + 0.2522) and 0.9994 for the internal standard (y = 1.5118x -2.0847). Construction of the analytical curves enabled us to describe the mathematical equations used for quantitation and calculations based on 1,8-cineol/internal standard peak area ratios.
The method based on the response of three replicates of an analytical curve at the sample size helped us to determine the detection (LOD) and quantitation (LOQ) limits. To this end, we obtained the residual standard deviation of the linear regression from three analytical curves set between 6.25 and 25.0 µg/mL according to the expressions: LOQ = 10 x Sb/Sa and LOD = 3.3 x Sb/Sa (where Sb is the standard deviation of the y intercept and Sa is the standard deviation of the slope of the three analytical curves). The LOD and LOQ values were 7.0 and 21.1 µg/mL, respectively.
Determination of accuracy at three concentration levels of the plant raw material (5.00, 10.00, and 20.00 mg/g), in four replicates, afforded a mean relative standard deviation (% RSD) of 1.4% (n= 12), with mean accuracy (BIAS) of -0.504, 1.310, and -1.390 for each assayed concentration, respectively. The mean recovery was 99.8% for 1,8-cineol, which allowed us to infer that the extraction method used herein recovered the chemical marker successfully.
For the syrup (0.25, 0.50, and 1.00 mg/g), the mean relative standard deviation was 1.3% (n= 12), with mean accuracy of -3.000, 1.500, and -2.000 for each assayed concentration, respectively. The mean recovery for 1,8-cineol was 100.5% (Table 2 ). To determine precision (intra-assay and inter-assay repeatability), we prepared and analyzed six samples of E. globulus leaves and syrup, on two different days. For intra-assay repeatability, the mean relative standard deviation was 1.5% for leaves and 0.9% for syrup. For inter-assay repeatability, the mean relative standard deviation was 1.9% for leaves and 1.3% for syrup. The results did not differ significantly -F calculated for leaves and syrup was lower than F tabled at 5% (Table 3) . 
The Youden test [14] provided the robustness results. The lower the numeric value for robustness, the less the influence of the modified parameter. For the plant material, extraction time, extraction temperature, and detection temperature had strong effects on this parameter. For the syrup, extraction time, organic solvent, and water quantity affected robustness. Table 4 describes the small changes in the nominal method conditions and the designed test.
For qualitative analysis, we subjected the essential oils of 12 Eucalyptus species to the validated method to verify whether it was able to distinguish large and small differences in the chemical composition of possible samples. 
GC-MS Fingerprinting of 12 Eucalyptus Species
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Chromatographic conditions:
The chromatographic analyses were optimized on a Hewlett-Packard 6890N gas chromatograph (Agilent Technologies, USA) equipped with a split/splitless injector inlet and a flame ionization detector. An HP-5 capillary column (Hewlett Packard, 5% phenyl-methyl-siloxane, 30 m x 0.32 mm x 0.25 µm) was employed. Hydrogen at a flow rate of 2.2 mL/min was the carrier gas. One µL of each sample was injected into the chromatograph, in the split mode (20:1). The injector and detector temperatures were set at 250°C and 270°C, respectively. The 20 min temperature program started at 75°C (held for 6 min); then, the temperature was increased to 90°C at 15 ºC/min and held there for 1 min, which was followed by an increase to 200°C at 10 °C/min and held there for 1 min. To identify the compounds, a GC-MS-QP2010 gas chromatograph equipped with a mass spectrometer detector (Shimadzu, Japan) was employed. For the analyses, an HP-5 MS capillary column was used under the same conditions applied during the GC-FID analyses. The ionization voltage was set at 70 eV.
Identification of the main compounds:
Identification of the main compounds was based on (I) comparison of the GC retention indices (RI) obtained by the Kovat's method with the RI of an analogous series of n-alkanes [15] reported in the literature; (II) comparison with the authentic 1,8-cineol standard; and (III) matching of the obtained mass spectra with spectral data available in the Wiley NBS database considering similarity greater than 95%.
Extraction of Eucalyptus sub-products and syrup formulation:
To extract the essential oils from the Eucalyptus species, 50.0 g of the dried leaves of each of the 12 assayed species was extracted by hydrodistillation with 350.0 mL of water in a Clevenger apparatus. The essential oils were stored at -20°C, until GC analysis.
The fluid extract of E. globulus was obtained from E. globulus leaves by fractionated percolation [16] . To this end, 100 g of the dried leaf powder was separated into 3 portions, of 50, 30, and 20 g. The first portion (50 g, column A) was macerated with 70% ethanol for 6 h and percolated using the same solvent, to afford an initial fraction of 20 mL (which was reserved) and 5 other 30 mL fractions. In the same way, the second portion of the leaf powder (30 g, column B) was macerated for 6 h together with the first 30 mL fraction from column A and percolated with the other 4 fractions. An initial fraction of 30 mL (which was also reserved) was obtained as well as another 4 fractions of 20 mL. Then, the third portion of the leaf powder (20 g; column C) was macerated for 6 h together with the first 20 mL fraction from column B, which was followed by percolation with the other 3 fractions and 70% ethanol, to furnish 50 mL. Finally, the reserved fractions were combined, to give 100 mL of fluid extract (1:1).
For the syrup formulation, 20.0 g of the fluid extract of E. globulus (1:1) was mixed with 180.0 g of invert sugar containing 0.05% of potassium sorbate. After homogenization, the syrup was stored in an amber flask at room temperature until GC analysis.
Preparation of sample solutions for GC analysis:
For the E. globulus leaves, a portion of 0.5 g of the powdered dried leaves was transferred to a 125 mL sealed Erlenmeyer flask and macerated with 20.0 mL of n-hexanes containing 100.0 µg/mL of TMB, for 2 h, in a shaker operating at 150 rpm, at 40°C. Then, the sample was cooled to room temperature and centrifuged at 20028 x g for 3 min, and the supernatant was reserved for GC analyses.
For the fluid extract of E. globulus, 5.0 mL of this extract (1:1) was transferred to a 50.0 mL volumetric flask and diluted to volume with n-hexanes containing TMB 100.0 µg/mL.
For the essential oils, 25.0 mg of each essential oil from the 12 Eucalyptus species was diluted to 50.0 mL in volumetric flasks containing n-hexanes and TMB 100.0 µg/mL.
For syrup, an aliquot of 10.0 g was transferred to a 125 mL sealed Erlenmeyer flask and homogenized with 5.0 mL of water. After that, 50.0 mL of n-hexanes containing TMB 100.0 µg/mL was added, and the sample was agitated in a shaker at 150 rpm for 1 h, at 42°C. Finally, the sample was cooled to room temperature and centrifuged at 20028 x g for 3 min, and the supernatant was used for GC analyses.
For the linearity studies and quantitation, 3 standard stock solutions were prepared by dissolving 40.0 mg of 1,8-cineol and 20.0 mg of TMB in n-hexanes placed in volumetric flasks. Serial dilutions were prepared, to achieve final 1,8-cineol concentrations ranging from 40.0 to 640.0 µg/mL and final TMB concentrations lying between 20.0 and 320.0 µg/mL.
The recovery studies for the plant raw material and syrup were undertaken by spiking the matrix, free of 1,8-cineol, with a known amount of this compound. Experiments were carried out at 3 concentration levels (high, intermediate, and low), in 4 replicates. For the plant raw material, 20.0 g of powdered leaves of E. citriodora were extracted with 150.0 mL of n-hexanes using a Soxhlet extractor. After that, the plant material, free of volatiles (as confirmed by GC analyses) was carefully dried. Next, 3 different concentrations of 1,8-cineol were incorporated into 0.5 g portions of the plant material using 1.0, 2.0, and 4.0 mL of a 1,8-cineol solution 2.5 mg/mL containing TMB 100.0 µg/mL. For the syrup, 3 different concentrations of 1,8-cineol were incorporated into portions of 10.0 g of invert sugar containing 0.05% of potassium sorbate; 0.5, 1.0, and 2.0 mL of a 1,8-cineol solution 5.0 mg/mL containing TMB 100.0 µg/mL in n-hexanes. Next, all the samples were processed as described in the preparation of sample solutions in the section on GC analysis.
Physicochemical characterization:
All the samples were characterized by means of official methods either described in the World Health Organization guidance [12] or in the Brazilian Pharmacopoeia, 4 th edition [13] .
